In the vast majority of the cases, INI1 immunostaining is of great diagnostic utility and can rapidly establish the diagnosis of MRT, when integrating this testing with the tumor morphology and immunophenotype in conjunction with other clinical features. The gene discussed is SMARCB1; the disease is neoplasm.